FDA conditionally approves QYLEKI as brand name for Quoin drug
Go back to FDA conditionally approves QYLEKI as brand name for Quoin drug| (NASDAQ: QNRX) | Delayed: 4.57 +0.20 (4.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.37 | 52 Week High | $ | |||
| Open | $4.40 | 52 Week Low | $ | |||
| Day High | $4.70 | P/E | N/A | |||
| Day Low | $4.33 | EPS | $ | |||
| Volume | 30,227 | |||||

